LIPT1 and ovarian cancer: In addition, high LIPT1 expression was significantly associated with increased DMFS in ovarian cancer (p = 0.013) and decreased post progression survival (PPS) in gastric cancer (p = 0.00077) (Supplementary Figures S2A–C).